SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty...
Clinical trial programs advance to further assess psychedelic-assisted psychotherapy utilizing lead drug candidate MYCO-001DENVER, March 24, 2022 (GLOBE NEWSWIRE) --...
Company received corrected FDA advice letter for Phase III trial with vilobelimab in hidradenitis suppurativaPositive Phase IIa data reported with...
TORONTO, March 24, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- In the world of emergent small cap...
Renew ‘Moonlight’ by Solei, CBN Vape Pen, Now Available Across Canada Solei Renew Moonlight CBN Solei Renew Moonlight CBNTORONTO, March...
New Features Aim to Help More Patients with Kidney Failure Receive an Organ Transplant CareDx AlloCare transplant app CareDx AlloCare...
WALTHAM, Mass., March 24, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company and leader in complement, today...
Fourth Quarter 2021 Revenue of $65.9 million and Full Year 2021 Revenue of $209.3 million, Reflecting 22% Quarterly and 159%...
Company to progress to second dose cohort in the MARVEL-1 study immediately, with first patient dosing expected in mid-2022 LONDON,...
Carson City, Nevada--(Newsfile Corp. - March 24, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a...
Clinical, technology and operations leadership veteran with a proven track record brings experience to Bloom's Operational Health and Health-Tech strategyVancouver,...
Expanded the Phase II/III LANCER clinical trial in patients with cardiovascular disease (CVD), or significant CVD risk factors, who are...
Opportunity to participate in all levels of the industry value chainLicence includes a comprehensive list of available psychedelic substances Expected...
Plume partners with transgender community organizations to support HRT access DENVER--(BUSINESS WIRE)--On March 25, 2022, Plume, the first and largest...
Company adds full suite of mobile patient engagement tools to its all-in-one EHR solution NEWBURY PARK, Calif.--(BUSINESS WIRE)--#EHR--Compulink Healthcare Solutions,...
Technology forward foundation enters next phase of growth with two additions to board BOSTON--(BUSINESS WIRE)--#Philantech--The Givinga Foundation, a 501(c)(3) public...
PearConnect™ platform for prescription digital therapeutics (PDTs) is now available for providers in the Epic App Orchard Gallery BOSTON--(BUSINESS WIRE)--Pear...
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #Benzinga--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and...
Post-surgical increase of endothelial function biomarker bioactive adrenomedullin (bio-ADM) concentrations predicts organ dysfunction.Bio-ADM may help identify patients with an increased...